{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:18:30Z","timestamp":1777655910487,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2026,4,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Parkinson\u2019s Disease (PD) and Alzheimer\u2019s Disease (AD) are still significant neurodegenerative\ndisorders that have few disease-modifying therapies. In this review, recent advances\nare assessed based on the strength of evidence for major molecular targets and the therapeutic approaches\nthat have been developed around those targets. Alpha-synuclein is a key target in PD, as\nindicated by genetic correlations, pathological distribution, and experimental evidence supporting\nits involvement in neuronal injury. Initial trials of alpha-synuclein antibodies and vaccines show\nevidence of target engagement, with yet-to-be-determined clinical outcomes. Interventions targeting\ngene-based dopamine synthesis restoration using AADC or multi-enzyme vectors have shown\nconsistent biological effects, with clinical variability, and determining optimized delivery and patient\nselection is necessary. In AD, amyloid-beta- and tau-directed interventions have produced\nmeasurable changes in biomarkers, and some agents have demonstrated a slight deceleration of deterioration\nat an early stage of the disease. The experience with previous BACE inhibitors also demonstrates\nthat excellent mechanistic rationale does not always translate into clinical efficacy in\nthe case of interference with critical physiological processes by target modulation. Regenerative\nmethods, such as stem-cell-based neuronal grafts in PD and neurotrophic factor gene delivery in\nAD, show potential to repair network function, but still pose issues regarding long-term stability,\nintegration, and the complexity of the procedures. Lifestyle-driven interventions, control of the\ngut microbiome, and neuromodulation methods also remain of interest and can be included in the\nlist of supportive strategies offered to complement molecular therapies. AI-based analytics and digital\ntools are helpful in the earlier detection, monitoring, and trial stratification. Taken together, existing\nevidence suggests that authenticated protein targets, neurotransmitter-targeted remedial\nstrategies, and technology-enabled accuracy methods are the most promising approaches for the\ndevelopment of disease-modifying therapies in PD and AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715273445849260403045802","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:52:21Z","timestamp":1776621141000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Innovations in Parkinson\u2019s and Alzheimer\u2019s Disease: Molecular Mechanisms and Emerging Strategies"],"prefix":"10.2174","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5055-7455","authenticated-orcid":true,"given":"S.","family":"Kasthuri","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Sri Balaji Vidyapeeth, Pondicherry, 607402, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-4337","authenticated-orcid":true,"given":"S.","family":"Padmavathi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, 607402, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9098-2882","authenticated-orcid":true,"given":"M.","family":"Jeevitha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Shri Venkateshwara College of Pharmacy, Pondicherry, 605102, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6367-0365","authenticated-orcid":true,"given":"Jayaraman","family":"Rajangam","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shri Venkateshwara College of Pharmacy, Pondicherry, 605102, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715273445849260403045802","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/252379\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715273445849260403045802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:04:21Z","timestamp":1777446261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/252379\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715273445849260403045802","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}